Impact of Agalsidase Alfa Therapy on Cardiac funcTION in Patients With Fabry's Cardiomyopathy
Clinical trial NCT03230591 · UNKNOWN
Trial details
- NCT number
- NCT03230591
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-07-12
- Primary completion
- 2025-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.